Search

Displaying results 9781 - 9790 of 10000 in total
  1. Drug

    ISB 1342

    go.drugbank.com/drugs/DB17251
    Investigational

    ISB 1342 is a bispecific antibody simultaneously targeting CD38 and CD3.

  2. Drug

    Cirtuvivint

    go.drugbank.com/drugs/DB17269
    Investigational

    Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.

  3. Drug

    PF-07799933

    go.drugbank.com/drugs/DB17489
    Investigational

    PF-07799933 is a BRAF class 2 inhibitor developed by Pfizer.

  4. Drug

    CA-170

    go.drugbank.com/drugs/DB15772
    Investigational

    CA-170 is a selective, small molecule inhibitor of PD-L1.

  5. Drug

    24-Homo-1,25-dihydroxyvitamin D3

    go.drugbank.com/drugs/DB15557
    Experimental

    24-Homo-1,25-dihydroxyvitamin D3 is a novel [vitamin D] analogue.

  6. Drug

    BA1301

    go.drugbank.com/drugs/DB19390
    Investigational

    BA1301 is an anti-Claudin18.2 monoclonal antibody conjugated with Duostatin-5.

  7. Drug

    Dalcetrapib

    go.drugbank.com/drugs/DB12181
    Investigational

    Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.

  8. Drug

    N-acetylmannosamine

    go.drugbank.com/drugs/DB12536
    Investigational

    N-acetylmannosamine is under investigation for the other of GNE Myopathy.

  9. Drug

    YMI024

    go.drugbank.com/drugs/DB32602
    Experimental

    YMI024 is a drug being investigated for inflammation-driven diseases.[L56081]

  10. Drug

    VB10.16

    go.drugbank.com/drugs/DB17512
    Investigational

    VB10.16 is a novel therapeutic antigen-presenting cell-targeting DNA vaccine developed to treat HPV16-positive cancers. … It is composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), a dimerization entity, and the part encoding a protein that specifically binds to antigen-presenting